LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.8550
+0.0018 (0.21%)
At close: Jan 30, 2026
LakeShore Biopharma Employees
LakeShore Biopharma had 573 employees as of March 31, 2025. The number of employees decreased by 185 or -24.41% compared to the previous year.
Employees
573
Change
-185
Growth
-24.41%
Revenue / Employee
$147,899
Profits / Employee
-$24,046
Market Cap
35.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 573 | -185 | -24.41% |
| Mar 31, 2024 | 758 | -15 | -1.94% |
| Mar 31, 2023 | 773 | -92 | -10.64% |
| Mar 31, 2022 | 865 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Oncotelic Therapeutics | 26 |
| Harvard Apparatus Regenerative Technology | 8 |
| ZIVO Bioscience | 7 |
| Provectus Biopharmaceuticals | 6 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
| Finch Therapeutics Group | 1 |
LakeShore Biopharma News
- 12 days ago - LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders - PRNewsWire
- 3 months ago - LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction - PRNewsWire
- 4 months ago - LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting - PRNewsWire
- 5 months ago - LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq - PRNewsWire
- 5 months ago - LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee - PRNewsWire
- 5 months ago - LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee - PRNewsWire
- 5 months ago - LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company - PRNewsWire
- 6 months ago - LakeShore Biopharma Announces Fiscal Year 2025 Financial Results - PRNewsWire